View Filing Data

Print Document View Excel Document

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Dec. 31, 2013	Feb. 17, 2014	Jun. 30, 2013
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2013
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2013
Entity Registrant Name	NATIONAL INSTRUMENTS CORP /DE/
Entity Central Index Key	0000935494
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Public Float			$ 2,113,947,245
Entity Common Stock, Shares Outstanding		126,033,283

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 230,263	$ 161,996
Short-term investments	163,149	173,166
Accounts receivable, net	180,680	187,060
Inventories, net	172,109	169,990
Prepaid expenses and other current assets	49,001	48,009
Deferred income taxes, net	33,393	27,479
Total current assets	828,595	767,700
Property and equipment, net	260,568	249,721
Goodwill	146,520	147,258
Intangible assets, net	82,310	93,913
Other long-term assets	25,558	26,177
Total assets	1,343,551	1,284,769
Current liabilities:
Accounts payable	56,614	65,080
Accrued compensation	25,189	29,978
Deferred revenue - current	96,117	90,714
Accrued expenses and other liabilities	17,627	34,373
Other taxes payable	29,808	24,811
Total current liabilities	225,355	244,956
Deferred income taxes	44,620	47,630
Liability for uncertain tax positions	23,572	20,920
Deferred revenue- long term	21,389	20,446
Other long-term liabilities	5,531	11,689
Total liabilities	320,467	345,641
Commitments and contingencies
Stockholders' equity:
Preferred stock: par value $0.01; 5,000,000 shares authorized; none issued and outstanding
Common stock: par value $0.01; 360,000,000 and 180,000,000 shares authorized; 125,690,240 and 122,878,690 shares issued and outstanding, respectively	1,257	1,229
Additional paid-in capital	604,330	532,845
Retained earnings	414,947	404,210
Accumulated other comprehensive income	2,550	844
Total stockholders' equity	1,023,084	939,128
Total liabilities and stockholders' equity	$ 1,343,551	$ 1,284,769

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2013	Dec. 31, 2012
Consolidated Balance Sheets [Abstract]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	360,000,000	180,000,000
Common stock, shares issued	125,690,240	122,878,690
Common stock, shares outstanding	125,690,240	122,878,690

Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net sales:
Product	$ 1,091,186	$ 1,054,849	$ 955,613
Software maintenance	81,372	87,494	81,667
GSA accrual		1,349	(13,107)
Total net sales	1,172,558	1,143,692	1,024,173
Cost of sales:
Product	299,854	274,839	235,839
Software maintenance	5,389	5,435	5,125
Total cost of sales	305,243	280,274	240,964
Gross profit	867,315	863,418	783,209
Operating expenses:
Sales and marketing	447,800	431,468	388,768
Research and development	234,796	222,994	199,071
General and administrative	87,418	85,239	82,658
Acquisition related adjustment	(1,316)	6,783
Total operating expenses	768,698	746,484	670,497
Operating income	98,617	116,934	112,712
Other income (expense):
Interest income	679	716	1,319
Net foreign exchange loss	(2,578)	(2,246)	(2,755)
Other income (expense), net	450	(567)	(142)
Income before income taxes	97,168	114,837	111,134
Provision for income taxes	16,655	24,700	17,062
Net income	$ 80,513	$ 90,137	$ 94,072
Basic earnings per share	$ 0.65	$ 0.74	$ 0.79
Weighted average shares outstanding - basic	124,558	121,973	119,836
Diluted earnings per share	$ 0.64	$ 0.73	$ 0.78
Weighted average shares outstanding - diluted	125,571	122,977	121,220
Dividends declared per share	$ 0.56	$ 0.56	$ 0.40

Consolidated Statements Of Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Statement Of Consolidated Comprehensive Income [Abstract]
Net income	$ 80,513	$ 90,137	$ 94,072
Other comprehensive income, before tax and net of reclassification adjustments:
Foreign currency translation adjustment	1,332	2,231	(1,236)
Unrealized gain (loss) on securities available-for-sale	(538)	56	(1,017)
Unrealized gain (loss) on derivative instruments	1,238	3,152	(305)
Other comprehensive income (loss), before tax	2,032	5,439	(2,558)
Tax provision related to items of other comprehensive income	(326)	(1,095)	(232)
Other comprehensive income (loss), net of tax	1,706	4,344	(2,790)
Comprehensive income	$ 82,219	$ 94,481	$ 91,282

Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flow from operating activities:
Net income	$ 80,513	$ 90,137	$ 94,072
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	67,974	58,686	49,897
Stock-based compensation	28,992	27,796	23,219
Tax expense (benefit) from deferred income taxes	(4,353)	1,853	(8,581)
Tax benefit from stock option plans	(2,407)	(2,198)	(5,151)
Changes in operating assets and liabilities:
Accounts receivable	6,820	(26,007)	(21,957)
Inventories	(1,563)	(36,154)	(11,817)
Prepaid expenses and other assets	(1,767)	(7,037)	(1,350)
Accounts payable	(8,604)	23,419	5,573
Deferred revenue	6,346	21,050	16,953
Taxes, accrued expenses and other liabilities	(2,472)	(19,029)	29,041
Net cash provided by operating activities	169,479	132,516	169,899
Cash flow from investing activities:
Capital expenditures	(47,796)	(89,073)	(54,830)
Capitalization of internally developed software	(14,883)	(11,721)	(12,065)
Additions to other intangibles	(5,182)	(1,890)	(5,035)
Acquisition, net of cash received		(25,481)	(73,558)
Purchases of short-term investments	(70,354)	(188,098)	(257,449)
Sales and maturities of short-term investments	80,371	238,436	166,104
Net cash used in investing activities	(57,844)	(77,827)	(236,833)
Cash flow from financing activities:
Proceeds from issuance of common stock	39,319	30,902	32,905
Deferred acquisition payments	(15,318)
Dividends paid	(69,776)	(68,401)	(47,961)
Tax benefit from stock option plans	2,407	2,198	5,151
Net cash used in financing activities	(43,368)	(35,301)	(9,905)
Net change in cash and cash equivalents	68,267	19,388	(76,839)
Cash and cash equivalents at beginning of period	161,996	142,608	219,447
Cash and cash equivalents at end of period	230,263	161,996	142,608
Interest	110	68	14
Income taxes	$ 10,510	$ 25,059	$ 2,393

Consolidated Statements Of Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income/(Loss) [Member]	Total
Balance at Dec. 31, 2010	$ 1,179	$ 407,713	$ 336,363	$ (710)	$ 744,545
Balance, Shares at Dec. 31, 2010	117,904,975
Net income			94,072		94,072
Other comprehensive income (loss)				(2,790)	(2,790)
Issuance of common stock under employee plans, including tax benefits	$ 27	32,878			32,905
Issuance of common stock under employee plans, including tax benefits, shares	2,715,253
Stock-based compensation		23,106			23,106
Business acquisition	$ 1	1,813			1,814
Business acquisition, shares	56,915
Dividends paid			(47,961)		(47,961)
Disqualified dispositions		6,320			6,320
Balance at Dec. 31, 2011	$ 1,207	471,830	382,474	(3,500)	852,011
Balance, Shares at Dec. 31, 2011	120,677,143
Net income			90,137		90,137
Other comprehensive income (loss)				4,344	4,344
Issuance of common stock under employee plans, including tax benefits	$ 22	30,879			30,901
Issuance of common stock under employee plans, including tax benefits, shares	2,201,547
Stock-based compensation		27,679			27,679
Dividends paid			(68,401)		(68,401)
Disqualified dispositions		2,457			2,457
Balance at Dec. 31, 2012	$ 1,229	532,845	404,210	844	$ 939,128
Balance, Shares at Dec. 31, 2012	122,878,690				122,878,690
Net income			80,513		$ 80,513
Other comprehensive income (loss)				1,706	1,706
Issuance of common stock under employee plans, including tax benefits	$ 28	39,291			39,319
Issuance of common stock under employee plans, including tax benefits, shares	2,811,550
Stock-based compensation		29,151			29,151
Dividends paid			(69,776)		(69,776)
Disqualified dispositions		3,043			3,043
Balance at Dec. 31, 2013	$ 1,257	$ 604,330	$ 414,947	$ 2,550	$ 1,023,084
Balance, Shares at Dec. 31, 2013	125,690,240				125,690,240

Operations And Summary Of Significant Accounting Policies

12 Months Ended

Dec. 31, 2013

Operations And Summary Of Significant Accounting Policies [Abstract]

Operations And Summary Of Significant Accounting Policies

Note 1 – Operations and summary of significant accounting policies

National Instruments Corporation is a Delaware corporation. We provide flexible application software and modular, multifunction hardware that users combine with industry-standard computers, networks and third party devices to create measurement, automation and embedded systems, which we also refer to as “virtual instruments.” Our approach gives customers the ability to quickly and cost-effectively design, prototype and deploy unique custom-defined solutions for their design, control and test application needs. We offer hundreds of products used to create virtual instrumentation systems for general, commercial, industrial and scientific applications. Our products may be used in different environments, and consequently, specific application of our products is determined by the customer and generally is not known to us. We approach all markets with essentially the same products, which are used in a variety of applications from research and development to production testing, monitoring and industrial control. The following industries and applications are served by us worldwide: advanced research, automotive, commercial aerospace, computers and electronics, continuous process manufacturing, education, government/defense, medical research/pharmaceutical, power/energy, semiconductors, automated test equipment, telecommunications and others. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America.

Principles of consolidation

The Consolidated Financial Statements include the accounts of National Instruments Corporation and its subsidiaries. All significant intercompany accounts and transactions have been eliminated.

Use of estimates

The preparation of our financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures of contingent assets and liabilities. We base our estimates on past experience and other assumptions that we believe are reasonable under the circumstances, and we evaluate these estimates on an ongoing basis. Our critical accounting policies are those that affect our financial statements materially and involve difficult, subjective or complex judgments by management. Although these estimates are based on management's best knowledge of current events and actions that may impact the company in the future, actual results may be materially different from the estimates.

Cash and cash equivalents

Cash and cash equivalents include cash and highly liquid investments with maturities of three months or less at the date of acquisition.

Short-Term Investments

We value our available-for-sale short term investments based on pricing from third party pricing vendors, who may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. We classify all of our fixed income available-for-sale securities as having Level 2 inputs. The valuation techniques used to measure the fair value of our financial instruments having Level 2 inputs were derived from non-binding market consensus prices that are corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques. We believe these sources reflect the credit risk associated with each of our available for sale short term investments. Short-term investments available-for-sale consists of debt securities issued by states of the U.S. and political subdivisions of the U.S., corporate debt securities and debt securities issued by U.S. government corporations and agencies as well as debt securities issued by foreign governments. All short-term investments available-for-sale have contractual maturities of less than 35 months.

Our investments are classified as available-for-sale and accordingly are reported at fair value, with unrealized gains and losses reported as other comprehensive income, a component of stockholders’ equity. Unrealized losses are charged against income when a decline in fair value is determined to be other than temporary. Investments with maturities beyond one year are classified as short-term based on their highly liquid nature and because such marketable securities represent the investment of cash that is available for current operations. The fair value of our short-term investments in debt securities at December 31, 2013 and December 31, 2012 was $163 million and $173 million, respectively. The decrease was due to the net sale of $10 million of short-term investments. We have $17 million U.S. dollar equivalent of German government sovereign debt and $16 million U.S. dollar equivalent of corporate bonds that are denominated in Euro at December 31, 2013. Our German government sovereign debt holdings have a maximum remaining maturity of 18 months and carry Aaa/AAA ratings.

We follow the guidance provided by FASB ASC 320 to assess whether our investments with unrealized loss positions are other than temporarily impaired. Realized gains and losses and declines in value judged to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net, in our Consolidated Statements of Income. We did not identify or record any other-than-temporary impairments during 2013, 2012 and 2011.

Accounts Receivable, net

Accounts receivable are recorded net of allowances for sales returns of $1.6 million and $2.1 million at December 31, 2013 and 2012, respectively, and net of allowances for doubtful accounts of $2.8 million and $2.8 million at December 31, 2013 and 2012, respectively. A provision for estimated sales returns is made by reducing recorded revenue based on historical experience. We analyze historical returns, current economic trends and changes in customer demand of our products when evaluating the adequacy of our sales returns allowance. Our allowance for doubtful accounts is based on historical experience. We analyze historical bad debts, customer concentrations, customer creditworthiness and current economic trends when evaluating the adequacy of our allowance for doubtful accounts.


(In thousands)
Year	Description		Balance at Beginning of Period		Provisions/ (Recapture)		Write-Offs/ (Recapture)		Balance at End of Period
2011	Allowance for doubtful accounts and sales returns	$	3,768	$	385	$	(88)	$	4,241
2012	Allowance for doubtful accounts and sales returns	$	4,241	$	1,216	$	587	$	4,870
2013	Allowance for doubtful accounts and sales returns	$	4,870	$	(43)	$	396	$	4,431

Inventories, net

Inventories are stated at the lower-of-cost or market. Cost is determined using standard costs, which approximate the first-in first-out (“FIFO”) method. Cost includes the acquisition cost of purchased components, parts and subassemblies, in-bound freight costs, labor and overhead. Market is replacement cost with respect to raw materials and is net realizable value with respect to work in process and finished goods.

Inventory is shown net of adjustment for excess and obsolete inventories of $5.5 million, $3.8 million and $4.2 million at December 31, 2013, 2012 and 2011, respectively.


(In thousands)
Year	Description		Balance at Beginning of Period		Provisions		Write-Offs		Balance at End of Period
2011	Adjustment for excess and obsolete inventories	$	3,340	$	3,554	$	2,689	$	4,205
2012	Adjustment for excess and obsolete inventories	$	4,205	$	1,824	$	2,185	$	3,844
2013	Adjustment for excess and obsolete inventories	$	3,844	$	3,488	$	1,873	$	5,459

Property and equipment, net

Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, which range from twenty to forty years for buildings, three to seven years for purchased internal use software and for equipment which are each included in furniture and equipment. Leasehold improvements are depreciated over the shorter of the life of the lease or the asset.

Intangible assets, net

We capitalize costs related to the development and acquisition of certain software products. Capitalization of costs begins when technological feasibility has been established and ends when the product is available for general release to customers. Technological feasibility for our products is established when the product is available for beta release. Amortization is computed on an individual product basis for those products available for market and is recognized based on the product’s estimated economic life, generally three years.

We use the services of outside counsel to search for, document, and apply for patents. Those costs, along with any filing or application fees, are capitalized. Costs related to patents which are abandoned are written off. Once a patent is granted, the patent costs are amortized ratably over the legal life of the patent, generally ten to seventeen years.

At each balance sheet date, the unamortized costs for all intangible assets are reviewed by management and reduced to net realizable value when necessary.

Goodwill

The excess purchase price over the fair value of net assets acquired is recorded as goodwill. As we have one operating segment, we allocate goodwill to one reporting unit for goodwill impairment testing. Goodwill is tested for impairment on an annual basis, and between annual tests if indicators of potential impairment exist, using a fair-value-based approach based on the market capitalization of the reporting unit. Our annual impairment test was performed as of February 28, 2013. No impairment of goodwill was identified during 2013 and 2012. Goodwill is deductible for tax purposes in certain jurisdictions.

Concentrations of credit risk

We maintain cash and cash equivalents with various financial institutions located in many countries throughout the world. At December 31, 2013, $142 million or 62% of our cash and cash equivalents was held in cash in various operating accounts with financial institutions throughout the world, and $88 million or 38% was held in money market accounts. The most significant of our operating accounts was our domestic Wells Fargo operating account which held approximately $15 million or 6% of our total cash and cash equivalents at a bank that carried A+/A2/AA- ratings at December 31, 2013. From a geographic standpoint, approximately $69 million or 30% of our cash was held in various domestic accounts with financial institutions and $161 million or 70% was held in various accounts outside of the U.S. with financial institutions. At December 31, 2013, our short-term investments consist of $17 million or 11% of foreign government bonds, $72 million or 44% of U.S. treasuries and agencies, $71 million or 43% of corporate notes, and $3 million or 2% in time deposits.

The goal of our investment policy is to manage our investment portfolio to preserve principal and liquidity while maximizing the return on our investment portfolio through the full investment of available funds. We place our cash investments in instruments that meet credit quality standards, as specified in our corporate investment policy guidelines. These guidelines also limit the amount of credit exposure to any one issue, issuer or type of instrument. Our cash equivalents and short-term investments carried ratings from the major credit rating agencies that were in accordance with our corporate investment policy. Our investment policy allows investments in the following: government and federal agency obligations, repurchase agreements (“Repos”), certificates of deposit and time deposits, corporate obligations, medium term notes and deposit notes, commercial paper including asset-backed commercial paper (“ABCP”), puttable bonds, general obligation and revenue bonds, money market funds, taxable commercial paper, corporate notes/bonds, municipal notes, municipal obligations, variable rate demand notes and tax exempt commercial paper. All such instruments must carry minimum ratings of A1/P1/F1, MIG1/VMIG1/SP1 and A2/A/A, as applicable, all of which are considered “investment grade”. Our investment policy for marketable securities requires that all securities mature in three years or less, with a weighted average maturity of no longer than 18 months with at least 10% maturing in 90 days or less. (See Note 2 – Cash, cash equivalents, short-term and long-term investments in Notes to Consolidated Financial Statements for further discussion and analysis of our investments).

Concentration of credit risk with respect to trade accounts receivable is limited due to our large number of customers and their dispersion across many countries and industries. The amount of sales to any individual customer did not exceed 3%, 7%, or 4% of revenue for the years ended December 31, 2013, 2012, or 2011, respectively. The largest trade account receivable from any individual customer at December 31, 2013 was approximately $6.1 million.

Key supplier risk

Our manufacturing processes use large volumes of high-quality components and subassemblies supplied by outside sources. Several of these components are available through sole or limited sources. Supply shortages or quality problems in connection with some of these key components could require us to procure components from replacement suppliers, which would cause significant delays in fulfillment of orders and likely result in additional costs. In order to manage this risk, we maintain safety stock of some of these single sourced components and subassemblies and perform regular assessments of suppliers performance, grading key suppliers in critical areas such as quality and “on-time” delivery.

Revenue recognition

We sell test and measurement solutions that include hardware, software licenses, and related services. Our sales are generally made under standard sales arrangements with payment terms ranging from net 30 days in the United States to net 30 days and up to net 120 days in some international markets. We offer rights of return and standard warranties for product defects related to our products. The rights of return are generally for a period of up to 30 days after the delivery date. Our standard warranties cover periods ranging from 90 days to three years. Our standard sales arrangements do not require product acceptance from the customer.

In recent years, we have made a concentrated effort to increase our revenue through the pursuit of orders with a value greater than $1.0 million. These orders often include contract terms that vary substantially from our standard terms of sale including product acceptance requirements and product performance evaluations which create uncertainty with respect to the timing of our ability to recognize revenue from such orders. These orders may also include most-favored customer pricing, significant discounts, extended payment terms and volume rebates, all of which may create uncertainty with respect to the amount and timing of revenue recognized from such orders.

Sales of application software licenses include post-contract support services. Other services include customer training, customer support, and extended warranties.

We recognize revenue when persuasive evidence of an arrangement exists, delivery has occurred, the price is fixed or determinable, and collectability is reasonably assured. Delivery is considered to have occurred when title and risk of loss have transferred to the customer. For most of our hardware and software sales, title and risk of loss transfer upon delivery. For services we recognize revenue when the service is provided, except for extended warranties for which revenue is recognized ratably over the warranty period.

We enter into certain arrangements in which we deliver multiple products and/or services. These arrangements may include hardware, software, and services. We separate consideration in multiple-deliverable arrangements by allocating to all deliverables using the relative selling price method at the inception of an arrangement. Revenue allocated to each element is then recognized when the basic revenue recognition criteria for that element have been met. The relative selling price method allocates any discount in the arrangement proportionally to each deliverable on the basis of each deliverable’s selling price. The selling price used for each deliverable will be based on vendor-specific objective evidence (“VSOE”) if available, third–party evidence if VSOE is not available, or estimated selling price if neither VSOE nor third-party evidence is available.

Software revenue recognition rules are applied to software sold on a stand-alone basis, and to software sold as part of a multiple element arrangement with hardware where the software is not required to deliver the tangible product's essential functionality. Under these rules, when VSOE of fair value is not available for a delivered element but is available for the undelivered element of a multiple element arrangement, sales revenue is recognized on the date the product is shipped, using the residual method, with the portion deferred that is related to undelivered elements. Undelivered elements related to software are generally restricted to post contract support and training and education. The amount of revenue allocated to these undelivered elements is based on the VSOE of fair value for those undelivered elements. Deferred revenue due to undelivered elements is recognized ratably over the service period or when the service is completed. When VSOE of fair value is not available for the undelivered element of a multiple element arrangement, sales revenue for the entire sales contract value is generally recognized ratably over the service period of the undelivered element, generally 12 months or when the service is completed in accordance with the subscription method.

The application of revenue recognition standards requires judgment, including whether a software arrangement includes multiple elements, and if so, whether VSOE of fair value exists for those elements. Changes to the elements in a software arrangement, the ability to identify VSOE for those elements, the fair value of the respective elements, and changes to a product’s estimated life cycle could materially impact the amount of our earned and unearned revenue. Judgment is also required to assess whether future releases of certain software represent new products or upgrades and enhancements to existing products.

Product revenue

Our product revenue is generated predominantly from the sales of measurement and automation products. Our products consist of application software and hardware components together with related driver software.

Software maintenance revenue

Software maintenance revenue is post contract customer support that provides the customer with unspecified upgrades/updates and technical support.

Shipping and handling costs

Our shipping and handling costs charged to customers are included in net sales, and the associated expense is recorded in cost of sales.

Warranty reserve

We offer a one-year limited warranty on most hardware products and extended two or three-year warranties on a subset of our hardware products, which is included in the sales price of many of our products. Provision is made for estimated future warranty costs at the time of the sale for the estimated costs that may be incurred under the basic limited warranty. Our estimate is based on historical experience and product sales.

The warranty reserve for the years ended December 31, 2013, 2012 and 2011 was as follows:



(In thousands)
		2013		2012		2011
Balance at the beginning of the period	$	1,435	$	1,271	$	921
Accruals for warranties issued during the period		3,737		2,270		2,954
Settlements made (in cash or in kind) during the period		(3,408)		(2,106)		(2,604)
Balance at the end of the period	$	1,764	$	1,435	$	1,271

Loss contingencies

We accrue for probable losses from contingencies including legal defense costs, on an undiscounted basis, when such costs are considered probable of being incurred and are reasonably estimable. We periodically evaluate available information, both internal and external, relative to such contingencies and adjust this accrual as necessary.

Advertising expense

We expense costs of advertising as incurred. Advertising expense for the years ended December 31, 2013, 2012 and 2011 was $13.7 million, $14.4 million and $14.7 million, respectively.

Foreign currency translation

The functional currency for our international sales operations is the applicable local currency. The assets and liabilities of these operations are translated at the rate of exchange in effect on the balance sheet date and sales and expenses are translated at average rates. The resulting gains or losses from translation are included in a separate component of other comprehensive income. Gains and losses resulting from re-measuring monetary asset and liability accounts that are denominated in a currency other than a subsidiary’s functional currency are included in net foreign exchange loss and are included in net income.

Foreign currency hedging instruments

All of our derivative instruments are recognized on the balance sheet at their fair value. We currently use foreign currency forward and purchased option contracts to hedge our exposure to material foreign currency denominated receivables and forecasted foreign currency cash flows.

On the date the derivative contract is entered into, we designate the derivative as a hedge of the variability of foreign currency cash flows to be received or paid (“cash flow” hedge) or as a hedge of our foreign denominated net receivable positions (“other derivatives”). Changes in the fair value of derivatives that are designated and qualify as cash flow hedges and that are deemed to be highly effective are recorded in other comprehensive income. These amounts are subsequently reclassified into earnings in the period during which the hedged transaction is realized. The gain or loss on the other derivatives as well as the offsetting gain or loss on the hedged item attributable to the hedged risk is recognized in current earnings under the line item “Net foreign exchange loss”. We do not enter into derivative contracts for speculative purposes.

We formally document all relationships between hedging instruments and hedged items, as well as our risk-management objective and strategy for undertaking various hedge transactions at the inception of the hedge. This process includes linking all derivatives that are designated as cash flow hedges to specific forecasted transactions. We also formally assess, both at the hedge’s inception and on an ongoing basis, whether the hedging instruments are highly effective in offsetting changes in cash flows of hedged items.

We prospectively discontinue hedge accounting if (1) it is determined that the derivative is no longer highly effective in offsetting changes in the fair value of a hedged item (forecasted transactions); or (2) the derivative is de-designated as a hedge instrument, because it is unlikely that a forecasted transaction will occur. When hedge accounting is discontinued, the derivative is sold and the resulting gains and losses are recognized immediately in earnings.

Income taxes

We account for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the expected tax consequences of temporary differences between the tax basis of assets and liabilities and their reported amounts. Valuation allowances are established when necessary to reduce deferred tax assets to amounts which are more likely than not to be realized. Judgment is required in assessing the future tax consequences of events that have been recognized in our financial statements or tax returns. Variations in the actual outcome of these future tax consequences could materially impact our financial position or our results of operations. In estimating future tax consequences, all expected future events are considered other than enactments of changes in tax laws or rates. We account for uncertainty in income taxes recognized in our financial statements using prescribed recognition thresholds and measurement attributes for financial statement disclosure of tax positions taken or expected to be taken on our tax returns. Our continuing policy is to recognize interest and penalties related to income tax matters in income tax expense.

Earnings per share

Basic earnings per share (“EPS”) is computed by dividing net income by the weighted average number of common shares outstanding during each period. Diluted EPS is computed by dividing net income by the weighted average number of common shares and common share equivalents outstanding (if dilutive) during each period. The number of common share equivalents, which include stock options and restricted stock units (“RSUs”), is computed using the treasury stock method.

The reconciliation of the denominators used to calculate basic EPS and diluted EPS for the years ended December 31, 2013, 2012 and 2011 are as follows:



	Years ended December 31,
(In thousands)	2013	2012	2011
Weighted average shares outstanding-basic	124,558	121,973	119,836
Plus: Common share equivalents
Stock options, restricted stock units	1,013	1,004	1,384
Weighted average shares outstanding-diluted	125,571	122,977	121,220

Stock awards to acquire 43,640 shares, 986,503 shares, and 477,019 shares for the years ended December 31, 2013, 2012, and 2011 were excluded in the computations of diluted EPS because the effect of including the stock awards would have been anti-dilutive.

On January 21, 2011, our Board of Directors declared a 3 for 2 stock split which was effected as a stock dividend, and paid on February 21, 2011, to stockholders of record on February 4, 2011. All per share data and numbers of common shares, where appropriate, have been retroactively adjusted to reflect the stock split.

Stock-based compensation

We account for stock-based compensation plans, which are more fully described in Note 11 – Authorized shares of common and preferred stock and stock-based compensation plans, using a fair-value method and recognize the expense in our Consolidated Statement of Income.

Comprehensive income

Our comprehensive income is comprised of net income, foreign currency translation and unrealized gains and losses on forward and option contracts and securities available-for-sale. Comprehensive income for 2013, 2012 and 2011 was $82.2 million, $94.5 million and $91.3 million, respectively.

Recently Issued Accounting Pronouncements

In February 2013, the FASB issued Accounting Standards Update (“ASU”) No. 2013-02, Reporting Amounts Reclassified Out of Accumulated Other Comprehensive Income, which amends ASC 220, Comprehensive Income. The amended guidance requires entities to provide information about the amounts reclassified out of accumulated other comprehensive income by component. Additionally, entities are required to present, either on the face of the financial statements or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income. The amended guidance does not change the current requirements for reporting net income or other comprehensive income. The amendments are effective prospectively for reporting periods beginning after December 15, 2012. We adopted this update in the first quarter of 2013. The adoption of ASU No. 2013-02 did not have a significant impact on the Company’s consolidated financial statements, but did amend the disclosures for accumulated other comprehensive income reclassified into income.

In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists, which amends ASC 740, Income Taxes. The amendments provide guidance on the financial statement presentation of an unrecognized tax benefit, as either a reduction of a deferred tax asset or as a liability, when a net operating loss carryforward, similar tax loss, or a tax credit carryforward exists. The amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013 and may be applied on either a prospective or retrospective basis. The provisions are effective for the Company’s Form 10-K for the year ending December 31, 2014. We do not expect the adoption of these provisions to have a significant impact on the Company’s consolidated financial statements.

Cash, Cash Equivalents And Short-Term Investments

12 Months Ended

Dec. 31, 2013

Cash, Cash Equivalents And Short-Term Investments [Abstract]

Cash, Cash Equivalents And Short-Term Investments

Note 2 – Cash, cash equivalents and short-term investments

The following tables summarize unrealized gains and losses related to our cash, cash equivalents, and short-term investments designated as available-for-sale:



(In thousands)		As of December 31, 2013
				Gross		Gross		Cumulative
		Adjusted Cost		Unrealized Gain		Unrealized Loss		Translation Adjustment		Fair Value
Cash	$	142,058	$	-	$	-	$	-	$	142,058
Money Market Accounts		88,205		-		-		-		88,205
Municipal bonds		-		-		-		-		-
Corporate bonds		71,964		16		(146)		(1,218)		70,616
U.S. treasuries and agencies		72,459		26		-		-		72,485
Foreign government bonds		18,409		-		(7)		(1,266)		17,136
Time deposits		2,912		-		-		-		2,912
Cash, cash equivalents, and short-term investments	$	396,007	$	42	$	(153)	$	(2,484)	$	393,412



(In thousands)		As of December 31, 2012
				Gross		Gross		Cumulative
		Adjusted Cost		Unrealized Gain		Unrealized Loss		Translation Adjustment		Fair Value
Cash	$	141,340	$	-	$	-	$	-	$	141,340
Money Market Accounts		20,656		-		-		-		20,656
Municipal bonds		1,465		1		-		-		1,466
Corporate bonds		8,708		-		(20)		(910)		7,778
U.S. treasuries and agencies		135,953		-		(28)		-		135,925
Foreign government bonds		27,947		57		-		(2,919)		25,085
Time deposits		2,912		-		-		-		2,912
Cash, cash equivalents, and short-term investments	$	338,981	$	58	$	(48)	$	(3,829)	$	335,162

The following tables summarize the contractual maturities of our short-term investments designated as available-for-sale:



(In thousands)		As of December 31, 2013
		Adjusted Cost		Fair Value
Due in less than 1 year	$	93,472	$	92,256
Due in 1 to 5 years		72,272		70,893
Total available-for-sale debt securities	$	165,744	$	163,149

Due in less than 1 year		Adjusted Cost		Fair Value
Corporate bonds	$	8,537	$	7,956
U.S. treasuries and agencies		72,459		72,485
Foreign government bonds		9,564		8,903
Time deposits		2,912		2,912
Total available-for-sale debt securities	$	93,472	$	92,256

Due in 1 to 5 years		Adjusted Cost		Fair Value
Corporate bonds		63,427		62,660
U.S. treasuries and agencies		-		-
Foreign government bonds		8,845		8,233
Total available-for-sale debt securities	$	72,272	$	70,893

Fair Value Measurements

12 Months Ended

Dec. 31, 2013

Fair Value Measurements [Abstract]

Fair Value Measurements

Note 3 – Fair value measurements

We define fair value to be the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, we consider the principal or most advantageous market that market participants may use when pricing the asset or liability.

We follow a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value measurement is determined based on the lowest level input that is significant to the fair value measurement. The three values of the fair value hierarchy are the following:

Level 1 – Quoted prices in active markets for identical assets or liabilities

Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly

Level 3 – Inputs that are not based on observable market data

Assets and liabilities measured at fair value on a recurring basis are summarized below:



(In thousands)		Fair Value Measurements at Reporting Date Using
Description		December 31, 2013		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Cash and cash equivalents available for sale:
Money Market Funds	$	88,205	$	88,205	$	-	$	-
Short-term investments available for sale:
Municipal bonds		-		-		-		-
Corporate bonds		70,616		-		70,616		-
U.S. treasuries and agencies		72,485		-		72,485		-
Foreign government bonds		17,136		-		17,136		-
Time deposits		2,912		2,912		-		-
Derivatives		6,908		-		6,908		-
Total Assets	$	258,262	$	91,117	$	167,145	$	-

Liabilities
Derivatives	$	(4,742)	$	-	$	(4,742)	$	-
Total Liabilities	$	(4,742)	$	-	$	(4,742)	$	-


(In thousands)		Fair Value Measurements at Reporting Date Using
Description		December 31, 2012		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets
Cash and cash equivalents available for sale:
Money Market Funds	$	20,656	$	20,656	$	-	$	-
Short-term investments available for sale:
Municipal bonds		1,466		-		1,466		-
Corporate bonds		7,778		-		7,778		-
U.S. treasuries and agencies		135,925		-		135,925		-
Foreign government bonds		25,085		-		25,085		-
Time deposits		2,912		2,912		-		-
Derivatives		4,246		-		4,246		-
Total Assets	$	198,068	$	23,568	$	174,500	$	-

Liabilities
Derivatives	$	(2,804)	$	-	$	(2,804)	$	-
Total Liabilities	$	(2,804)	$	-	$	(2,804)	$	-

We value our available-for-sale short-term investments based on pricing from third party pricing vendors, who may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. We classify all of our fixed income available-for-sale securities as having Level 2 inputs. The valuation techniques used to measure the fair value of our financial instruments having Level 2 inputs were derived from non-binding market consensus prices that are corroborated by observable market data, quoted market prices for similar instruments, or pricing models, such as discounted cash flow techniques. We believe all of these sources reflect the credit risk associated with each of our available-for-sale short-term investments. Short-term investments available-for-sale consists of debt securities issued by states of the U.S. and political subdivisions of the U.S., corporate debt securities and debt securities issued by U.S. government organizations and agencies as well as debt securities issued by foreign governments. All short-term investments available-for-sale have contractual maturities of less than 35 months.

Derivatives include foreign currency forward and option contracts. Our foreign currency forward contracts are valued using an income approach (Level 2) based on the spot rate less the contract rate multiplied by the notional amount. Our foreign currency option contracts are valued using a market approach based on the quoted market prices which are derived from observable inputs including current and future spot rates, interest rate spreads as well as quoted market prices of similar instruments. We consider counterparty credit risk in the valuation of our derivatives. However, counterparty credit risk did not impact the valuation of our derivatives during the year ended December 31, 2013. There were not any transfers in or out of Level 1 or Level 2 in the year ended December 31, 2013.

Our foreign government bonds consist of German government sovereign debt denominated in Euro with maximum remaining maturities of 18 months. Our short-term investments do not involve sovereign debt from any other country in Europe.

We did not have any items that were measured at fair value on a nonrecurring basis at December 31, 2013 and December 31, 2012.

The carrying value of net accounts receivable and accounts payable contained in the Consolidated Balance Sheets approximates fair value.

- Definition

The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19279-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19207-110258

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7578670&loc=d3e19190-110258

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 6
-Footnote 4
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 33
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Derivative Instruments And Hedging Activities

12 Months Ended

Dec. 31, 2013

Derivative Instruments And Hedging Activities [Abstract]

Derivative Instruments And Hedging Activities

Note 4 – Derivative instruments and hedging activities

We recognize all of our derivative instruments as either assets or liabilities in our statement of financial position at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, we designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

We have operations in over 50 countries. Sales outside of the Americas accounted for approximately 59%, 60%, and 60% of our revenues during the years ended December 31, 201, 2012 and 2011, respectively. Our activities expose us to a variety of market risks, including the effects of changes in foreign currency exchange rates. These financial risks are monitored and managed by us as an integral part of our overall risk management program.

We maintain a foreign currency risk management strategy that uses derivative instruments (foreign currency forward and purchased option contracts) to help protect our earnings and cash flows from fluctuations caused by the volatility in currency exchange rates. Movements in foreign currency exchange rates pose a risk to our operations and competitive position, since exchange rate changes may affect our profitability and cash flow, and the business or pricing strategies of our non-U.S. based competitors.

The vast majority of our foreign sales are denominated in the customers’ local currency. We purchase foreign currency forward and option contracts as hedges of forecasted sales that are denominated in foreign currencies and as hedges of foreign currency denominated receivables. These contracts are entered into to help protect against the risk that the eventual dollar-net-cash inflows resulting from such sales or firm commitments will be adversely affected by changes in exchange rates. We also purchase foreign currency forward contracts as hedges of forecasted expenses that are denominated in foreign currencies. These contracts are entered into to help protect against the risk that the eventual dollar-net-cash outflows resulting from foreign currency operating and cost of revenue expenses will be adversely affected by changes in exchange rates.

We designate foreign currency forward and purchased option contracts as cash flow hedges of forecasted revenues or forecasted expenses. In addition, we hedge our foreign currency denominated balance sheet exposures using foreign currency forward contracts that are not designated as hedging instruments. None of our derivative instruments contain a credit-risk-related contingent feature.

Cash flow hedges

To help protect against the reduction in value caused by a fluctuation in foreign currency exchange rates of forecasted foreign currency cash flows resulting from international sales over the next one to three years, we have instituted a foreign currency cash flow hedging program. We hedge portions of our forecasted revenue and forecasted expenses denominated in foreign currencies with forward and purchased option contracts. For forward contracts, when the dollar strengthens significantly against the foreign currencies, the change in the present value of future foreign currency cash flows may be offset by the change in the fair value of the forward contracts designated as hedges. For option contracts, when the dollar strengthens significantly against the foreign currencies, the change in the present value of future foreign currency cash flows may be offset by the change in the fair value of the option contracts net of the premium paid designated as hedges. Our foreign currency purchased option contracts are purchased “at-the-money” or “out-of-the-money”. We purchase foreign currency forward and option contracts for up to 100% of our forecasted exposures in selected currencies (primarily in Euro, Japanese yen, Malaysian ringgit, British pound and Hungarian forint) and limit the duration of these contracts to 40 months or less.

For derivative instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (“OCI”) and reclassified into earnings in the same line item (net sales, operating expenses, or cost of sales) associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings or expenses during the current period and are classified as a component of “net foreign exchange loss”. Hedge effectiveness of foreign currency forwards and purchased option contracts designated as cash flow hedges are measured by comparing the hedging instrument’s cumulative change in fair value from inception to maturity to the forecasted transaction’s terminal value.

We held forward contracts with the following notional amounts:



(In thousands)		US Dollar Equivalent
		As of December 31, 2013		As of December 31, 2012
Euro	$	75,886	$	84,770
Japanese yen		23,284		42,209
Hungarian forint		21,159		36,005
British pound		14,869		-
Malaysian ringgit		4,426		-
Total forward contracts notional amount	$	139,624	$	162,984

The contracts in the foregoing table had contractual maturities of 36 months or less at December 31, 2013 and December 31, 2012.

At December 31, 2013, we expect to reclassify $157,000 of gains on derivative instruments from accumulated OCI to net sales during the next twelve months when the hedged international sales occur, $910,000 of gains on derivative instruments from accumulated OCI to cost of sales when the cost of sales are incurred and $409,000 of gains on derivative instruments from accumulated OCI to operating expenses during the next twelve months when the hedged operating expenses occur. Expected amounts are based on derivative valuations at December 31, 2013. Actual results may vary as a result of changes in the corresponding exchange rates subsequent to this date.

We did not record any ineffectiveness from our hedges during the years ended December 31, 2013 and 2012.

Other Derivatives

Other derivatives not designated as hedging instruments consist primarily of foreign currency forward contracts that we use to hedge our foreign denominated net receivable or net payable positions to protect against the change in value caused by a fluctuation in foreign currency exchange rates. We typically attempt to hedge up to 90% of our outstanding foreign denominated net receivables or net payables and typically limit the duration of these foreign currency forward contracts to approximately 120 days. The gain or loss on the derivatives as well as the offsetting gain or loss on the hedge item attributable to the hedged risk is recognized in current earnings under the line item “net foreign exchange loss”. As of December 31, 2013 and December 31, 2012, we held foreign currency forward contracts with a notional amount of $70 million and $69 million, respectively.

The following tables present the fair value of derivative instruments on our Consolidated Balance Sheets and the effect of derivative instruments on our Consolidated Statements of Income.

Fair Values of Derivative Instruments:



	Asset Derivatives
	December 31, 2013			December 31, 2012
(In thousands)
	Balance Sheet Location		Fair Value	Balance Sheet Location		Fair Value
Derivatives designated as hedging instruments
Foreign exchange contracts - ST forwards	Prepaid expenses and other current assets	$	4,825	Prepaid expenses and other current assets	$	2,956

Foreign exchange contracts - LT forwards	Other long-term assets		1,719	Other long-term assets		1,046
Total derivatives designated as hedging instruments		$	6,544		$	4,002

Derivatives not designated as hedging instruments

Foreign exchange contracts - ST forwards	Prepaid expenses and other current assets	$	364	Prepaid expenses and other current assets	$	244
Total derivatives not designated as hedging instruments		$	364		$	244

Total derivatives		$	6,908		$	4,246



	Liability Derivatives
	December 31, 2013			December 31, 2012
(In thousands)
	Balance Sheet Location		Fair Value	Balance Sheet Location		Fair Value
Derivatives designated as hedging instruments
Foreign exchange contracts - ST forwards	Accrued expenses and other liabilities	$	(3,350)	Accrued expenses and other liabilities	$	(1,292)

Foreign exchange contracts - LT forwards	Other long-term liabilities		-	Other long-term liabilities		(798)
Total derivatives designated as hedging instruments		$	(3,350)		$	(2,090)

Derivatives not designated as hedging instruments

Foreign exchange contracts - ST forwards	Accrued expenses and other liabilities	$	(1,392)	Accrued expenses and other liabilities	$	(714)
Total derivatives not designated as hedging instruments		$	(1,392)		$	(714)

Total derivatives		$	(4,742)		$	(2,804)

The following tables present the effect of derivative instruments on our Consolidated Statements of Income for the years ended December 31, 2013 and 2012, respectively:



December 31, 2013
(In thousands)
Derivatives in Cash Flow Hedging Relationship		Gain or (Loss) Recognized in OCI on Derivative (Effective Portion)	Location of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)		Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)		Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion)
Foreign exchange contracts - forwards and options	$	(178)	Net sales	$	3,173	Net foreign exchange gain (loss)	$	-

Foreign exchange contracts - forwards and options		985	Cost of sales		118	Net foreign exchange gain (loss)		-

Foreign exchange contracts - forwards and options		431	Operating expenses		87	Net foreign exchange gain (loss)		-
Total	$	1,238		$	3,378		$	-